Anti-carbamylated protein antibodies and the risk for arthritis
摘要
Antibodies against citrullinated protein antigens (ACPA) have shown their relevance for the diagnosis and possibly pathogenesis in arthritis. The present invention provides means and methods for determining antibodies against homocitrulline containing proteins or carbamylated proteins/peptides (anti-Car P) for the classification of individuals suffering from or at risk of suffering from arthritis.
申请公布号
AU2012211537(B2)
申请公布日期
2016.12.08
申请号
AU20120211537
申请日期
2012.02.01
申请人
Academisch Ziekenhuis Leiden h.o.d.n. LUMC
发明人
Trouw, Leendert Adrianus;Toes, Reinaldus Everadus Maria;Huizinga, Thomas Willem Johannes;Van Veelen, Petrus Antonius;Cerami, Anthony;SHI, Jing